enzacamene

enzacamene

 [en″zah-kam´ēn]
an absorber of ultraviolet radiation, used topically as a sunscreen.

enzacamene

/en·za·cam·ene/ (en″zah-kam´ēn) an absorber of ultraviolet radiation, used topically as a sunscreen.

enzacamene

[en′zah-kam′ēn]
an absorber of ultraviolet radiation, used topically as a sunscreen.
References in periodicals archive ?
Those ingredients--amiloxate, enzacamene, octyl triazone, bemotrizinol, bisoctrizole, iscotrizinol, ecamsule and drometrizole trisiloxane--have been languishing on the Time and Extent Application list, awaiting FDA's approval for years; most of them waiting for a decade or longer
These ingredients--amiloxate, enzacamene, octyl triazone, bemotrizinol, bisoctrizole, iscotrizinol, ecamsule and drometrizole trisiloxane--can already be found in sun care formulas throughout the world--with the exception of the US.
24, the agency sent the remaining two letters to the suppliers of ecamsule and enzacamene citing that their application was lacking the necessary data to support their safety and effectiveness.
But with the passage of The Sunscreen Innovation Act in January, formulators may eventually have as many as eight new ingredients to work with, including amiloxate, bemotrizinol, bisoctrizol, drometrizole trisiloxane, ecamsule, enzacamene, isocotrizinol and octly triazone--just don't expect these ingredients to show up on product labels anytime soon.
It began with the submission to the FDA of three ingredients (amiloxate, enzacamene and octly triazone) followed by the submission in 2005 of three additional ingredients (bemotrizinol, bisoctrizol and isocotrizinol), and finally, two L'Oreal ingredients (ecamsule in 2007 and drometrizole trisiloxane in 2009) were submitted to the FDA for approval for use in the USA under the TEA guidelines (See Table I).
Enzacamene is a camphor derivative that has received negative publicity in Europe.
TABLE I: EUROPEAN INGREDIENTS UNDER TEA-FDA REVIEW Ingredient TEA Date Docket Amiloxate 8/14/2002 FDA-2003-N-0196 Enzacamene 8/21/2002 FDA-2003-N-0196 Octyl Triazone 8/21/2002 FDA-2003-N-0196 Bemotrizinol 4/11/2005 FDA-2005-N-0453 Bisoctrizole 4/11/2005 FDA-2005-N-0453 Isocotrizinol 9/16/2005 FDA-2006-0-0314 Ecamsule 9/18/2007 FDA-2008-N-0474 Drometrizole 1/21/2009 FDA-2003-N-0196 Trisiloxane TABLE II: FDA APPROVED LIST OF ULTRAVIOLET FILTERS (17) Aminobenzoio acid(X) Octisalate# Avobenzone(A)# Oxybenzone (A)# Cinoxate(X) Padimate 0(?
These five ingredients are amiloxate, enzacamene, octyl triazone, bemotrizinol and bisoctrizol.
EUROPEAN INGREDIENTS UNDER FDA REVIEW Ingredient TEA Date Docket Amiloxate 8/14/2002 FDA-2003-N-0196 Enzacamene 8/21/2002 FDA-2003-N-0196 Octyl Triazone 8/21/2002 FDA-2003-N-0196 Bemotrizinol 4/11/2005 FDA-2005-N-0453 Bisoctrizole 4/11/2005 FDA-2005-N-0453 Isocotrizinol 9/16/2005 FDA-2006-O-0314 Ecamsule 9/18/2007 FDA-2008-N-0474 Drometrizole Trisiloxane 1/21/2009 FDA-2003-N-0196
Amiloxate from Symrise, Enzacamene from EMD and Octyl triazone from BASF were submitted August 2002 and they were the first to receive a notice of eligibility (7/11/2003, 68FR41386).
They are: Amiloxate, Enzacamene, Octyl triazone, two Tinosorbs, Uvasorb and Ecamsule.